Dermatology

TOLMAR is an industry leader in the development and manufacturing of prescription topical ointments, creams, gels, and lotions for dermatologic applications.

Lidocaine_Prilocaine_Cream-300x225Lidocaine and Prilocaine Cream USP, 2.5%/2.5%

Lidocaine and Prilocaine Cream USP, 2.5%/2.5% (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on

  • Normal intact skin for local analgesia
  • Genital mucous membranes for superficial minor surgery, and as pretreatment for infiltration anesthesia

Full Prescribing Information


Mometasone_Furoate_Ointment-300x225Mometasone Furoate Ointment USP, 0.1%

Mometasone Furoate Ointment USP, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 2 years of age.

Full Prescribing Information


Mometasone-Furoate-Cream-300x225Mometasone Furoate Cream USP, 0.1%

Mometasone Furoate Cream USP, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 2 years of age.

Full Prescribing Information


Mometasone-Furoate-Topical-Solution-300x225Mometasone Furoate Topical Solution USP, 0.1% (Lotion)

Mometasone Furoate Topical Solution USP, 0.1% (Lotion) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 12 years of age.

Full Prescribing Information


Betamethasone Dipropionate Cream USP, 0.05% (Augmented)

Betamethasone Dipropionate Cream USP, 0.05% (Augmented) is a high-potency corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years and older.

Full Prescribing Information


Erythromycin-and-Benzyol-Peroxide-300x225Erythromycin and Benzoyl Peroxide Topical Gel USP

Erythromycin and Benzoyl Peroxide Topical Gel USP, 3% and 5% is indicated for the topical treatment of acne vulgaris.

Full Prescribing Information


Fluticasone-300x225Fluticasone Propionate Cream USP, 0.05%

Fluticasone Propionate Cream is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Fluticasone Propionate Cream may be used with caution in pediatric patients 3 months of age or older. The safety and efficacy of drug use for longer than 4 weeks in this population have not been established. The safety and efficacy of Fluticasone Propionate Cream in pediatric patients fewer than 3 months of age have not been established.

Full Prescribing Information


Ketoconazole Shampoo, 2%

Ketoconazole Shampoo, 2% is indicated for the treatment of tinea (pityriasis) versicolor caused by or presumed to be caused by Pityrosporum orbiculare (also known as Malassezia furfur or M. orbiculare).

Full Prescribing Information


Metronidazole_Gel_55g-300x225Metronidazole Topical Gel USP, 0.75%

Metronidazole Topical Gel USP, 0.75% is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.

Full Prescribing Information


Metronidazole_Vaginal_Gel_DSC_0871-300x225Metronidazole Vaginal Gel USP, 0.75%

Metronidazole Vaginal Gel USP, 0.75% is indicated in the treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis).

NOTE: For purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that: (a) has a pH of greater than 4.5; (b) emits a “fishy” amine odor when mixed with a 10% KOH solution; and (c) contains clue cells on microscopic examination. Gram’s stain results consistent with a diagnosis of bacterial vaginosis include: (a) markedly reduced or absent Lactobacillus morphology; (b) predominance of Gardnerella morphotype; and (c) absent or few white blood cells.

Other pathogens commonly associated with vulvovaginitis (e.g., Trichomonas vaginalis, Chlamydia trachomatis, N. gonorrhoeae, Candida albicans, and Herpes simplex virus) should be ruled out.

Full Prescribing Information


Ciclopirox-Nail-Lacquer-300x225Ciclopirox Topical Solution, 8% (Nail Lacquer)

Ciclopirox Topical Solution, 8% (Nail Lacquer), as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement due to Trichophyton rubrum. The comprehensive management program includes removal of the unattached, infected nails as frequently as once a month by a healthcare professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures.

Full Prescribing Information


Calcipotriene_Solution-300x225Calcipotriene Topical Solution, 0.005% (Scalp Solution)

Calcipotriene Topical Solution, 0.005% (Scalp Solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Full Prescribing Information


Imiquimod-Cream-300x225Imiquimod Cream, 5%

Imiquimod Cream is indicated for the topical treatment of

  • Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AK) on the face or scalp in immunocompetent adults
  • External genital and perianal warts/condyloma acuminata in patients 12 years old or older

Limitations of Use: Efficacy was not demonstrated for Molluscum contagiosum in children aged 2-12.

Full Prescribing Information


Calcipotriene_Cream-300x225Calcipotriene Cream, 0.005%

Calcipotriene Cream, 0.005% is indicated for the treatment of plaque psoriasis. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Full Prescribing Information


Metronidazole_Gel_55g1-300x225Metronidazole Gel USP, 1%

Metronidazole Gel USP, 1% is a nitroimidazole indicated for the topical treatment of inflammatory lesions of rosacea.

Full Prescribing Information


adapalene-300x163Adapalene Gel, 0.3%

Adapalene Gel, 0.3% is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

Full Prescribing Information


Calcipotriene_Betamethasone_Dipropionate_Group_DSC_0893-300x225Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment

Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and older.

Full Prescribing Information


Diclofenac-Sodium-Gel-300x225Diclofenac Sodium Gel, 3%

Diclofenac Sodium Gel, 3% is indicated for the topical treatment of actinic keratoses (AK). Sun avoidance is indicated during therapy.

Full Prescribing Information


TOLMAR’s generic dermatology portfolio is marketed in the U.S. by Sandoz and Impax Laboratories.

TOLMAR’s products were all developed and manufactured in Fort Collins, Colorado.